Ilasis develops a patented femtosecond laser system specifically designed for capsulorhexis in cataract surgery, providing a non-invasive handpiece that simplifies the cutting process. This technology enhances surgical precision while significantly reducing costs, enabling more surgeons to access effective cataract treatment.
Funding
$7.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Manual capsulorhexis during cataract surgery can be technically challenging, leading to inconsistent incision sizes and shapes, which can increase the risk of complications such as anterior capsule tears. Traditional femtosecond laser systems for capsulotomy are often expensive, limiting accessibility for many surgeons and patients.
Solution
Ilasis has developed Rx by Helix Surgical, a femtosecond laser system designed to simplify and improve the precision of capsulorhexis in cataract surgery. This patented, cost-effective laser solution offers a non-invasive handpiece that creates a seamless cutting solution for capsulotomy. The system aims to empower surgeons to achieve excellence in eye surgery with a faster learning curve and more accessible technology.
Target Audience
The primary target audience includes ophthalmologists and cataract surgeons seeking to improve the precision and efficiency of capsulorhexis while reducing costs.
Features
- Patented femtosecond laser technology specifically for capsulorhexis
- Non-invasive handpiece for simplified and precise cutting
- Streamlined design for a faster learning curve
- Cost-effective solution compared to traditional femtosecond lasers
- Seamless capsulotomy creation